topic

Industry Q&A

Question-and-answer interviews with leaders and innovators across the HME and home health industry.

  • Q&A: Jim Greatorex, Owner, Black Bear Medical

    Nufoot Beyond Barefoot nufoot.com 2013 Innovative HME Retail Product Awards
    Read More →: Q&A: Jim Greatorex, Owner, Black Bear Medical

  • HME Industry Q&A with John G. Beard, Alacare Home Health & Hospice

    HC: How have Medicare’s reimbursement changes affected the Home Healthcare industry? JB: Since Medicare established the Home Heath Prospective Payment System (HHPPS) on October 1, 2000, Home Health Agencies (HHAs) have been subjected to annual adjustments based on amendments to the law along with regulatory changes. The National Episodic Reimbursement Rate is about the same amount today as it was in 2000 and the Case Mix Weight adjustments have become more restrictive in terms of addressing the needs of older, frailer Medicare patients who have an adequate Home Health Care Benefit to address all their homecare needs. Medicare is now seeking to address the problems that have resulted from a system that has incorrectly addressed the management of chronic conditions via an acute care, institutional…
    Read More →: HME Industry Q&A with John G. Beard, Alacare Home Health & Hospice

  • HME Industry Q&A with Alan Lynch, ATLAS

    HC: What unmet needs or challenges led to the development of the ATLAS system? AL: We recognize that our industry is in the middle of a very pivotal time for mobility and HME providers. They are facing the challenge of providing equipment on reduced margins and with increased scrutiny of their documentation. In addition to these challenges, providers are also confronted with the risk of refused payments if the documentation is found to be inadequate during an audit. ATLAS was born as out of necessity as the provider side of our business searched for a software solution to allow us to tackle these challenges. As we looked at what was available in the market we found many good options, but didn’t feel that any of…
    Read More →: HME Industry Q&A with Alan Lynch, ATLAS

  • HME Industry Q&A with Doug Francis, Drive Medical

    HC: Tell us about the 5 Pillar Solution to help providers confront competitive bidding. DF: Over the years we have witnessed a steady decline in reimbursement. However, with the recent CMS changes our provider partners are experiencing drastic reductions. Our industry is under attack, and providers are feeling the pinch and being forced to rethink how they run their business. The challenge for the provider doesn’t end with CMS. As the HME industry focuses on the implications of competitive bidding, big-box retailers and Internet providers are rushing into this space. Our data shows that these companies are actually having success selling HME-related items deemed impossible to sell through traditional HME providers. In the past HMEs have been activity based organizations, basically filling prescriptions for what…
    Read More →: HME Industry Q&A with Doug Francis, Drive Medical

  • A Dangerous Waiting Game

    Invest in business automation now to adapt to radical HME industry changes
    Read More →: A Dangerous Waiting Game

  • HME Industry Q&A

    A conversation with Ted Raquet, Pride Mobility Products Corporation
    Read More →: HME Industry Q&A

  • HME Industry Q&A

    A conversation with Daniel Hayes, president and CEO of HealthCall, LLC
    Read More →: HME Industry Q&A

  • HME Industry Q&A with John Frank

    A conversation with John Frank, Philips Home Healthcare Solutions
    Read More →: HME Industry Q&A with John Frank

  • Abbott to Acquire TheraSense for $1.2 Billion

    Abbott Park, Ill. Abbott Laboratories will acquire diabetes test-maker TheraSense Inc., which manufactures FreeStyle blood glucose self-monitoring systems, for $1.2 billion. TheraSense, Alameda, Calif., entered the market in mid-2000 and has specialized in products requiring very small blood sample sizes. The company has requested FDA clearance to market its FreeStyle Navigator, which is designed to provide real-time glucose data, hypo- and hyperglycemic alarms and trend analysis. The device continuously monitors glucose levels and transmits the results to a wireless receiver small enough to be carried in a pocket. Another TheraSense product, the CozMore Insulin Technology System, is under development with Deltec Inc., which provides infusion systems. Set to launch this year, the system combines the TheraSense glucose testing system and insulin delivery options if blood-sugar…
    Read More →: Abbott to Acquire TheraSense for $1.2 Billion

OUR DIGITAL PARTNERS

trending

From Our Partners